柳敬相
Department
临床药理学科
Specialty
网上预约
Personalized Optimal Pharmacotherapy
,
Clinical trial for drug development
Education / Career
| Article | Pioglitazone-induced alterations of purine metabolism in healthy male subjects | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202405 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38771175/ | ||
| Article | Pharmacokinetics, pharmacodynamics and safety of oral formulation (CG-750) of ivaltinostat, a histone deacetylase inhibitor, compared to IV formulation (CG-745) | ||
|---|---|---|---|
| Announcements | Br J Clin Pharmacol | Date of publication | 202404 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38263733/ | ||
| Article | A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects | ||
|---|---|---|---|
| Announcements | Pharmaceuticals (Basel) | Date of publication | 202404 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38675482/ | ||
| Article | Safety, Tolerability, and Pharmacokinetics of a Novel Macrocyclic Gadolinium-Based Contrast Agent, HNP-2006, in Healthy Subjects | ||
|---|---|---|---|
| Announcements | Invest Radiol | Date of publication | 202403 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37493284/ | ||
| Article | Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjects | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202403 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38436494/ | ||
| Article | Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202403 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38501281/ | ||
| Article | Establishment of Advanced Regulatory Innovation for Clinical Trials Transformation (ARICTT): a multi-stakeholder public-private partnership-based organization to accelerate the transformation of clinical trials | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202403 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38586121/ | ||
| Article | The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidance | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202403 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38586122/ | ||
| Article | Topiramate dosage optimization for effective antiseizure management via population pharmacokinetic modeling | ||
|---|---|---|---|
| Announcements | Ann Clin Transl Neurol | Date of publication | 202402 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38062636/ | ||
| Article | Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects | ||
|---|---|---|---|
| Announcements | Invest New Drugs | Date of publication | 202402 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38099989/ | ||
| Article | Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects | ||
|---|---|---|---|
| Announcements | Clin Pharmacol Drug Dev | Date of publication | 202402 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38156730/ | ||
| Article | Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Omega-3-Acid Ethyl Esters and the Corresponding Loose Combination in Healthy Korean Male Subjects | ||
|---|---|---|---|
| Announcements | Drug Des Devel Ther | Date of publication | 202402 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/38352172/ | ||
| Article | Pharmacokinetic Comparison Between a Fixed-Dose Combination of Empagliflozin L-Proline/Metformin and Empagliflozin/Metformin in Healthy Korean Subjects | ||
|---|---|---|---|
| Announcements | Clin Pharmacol Drug Dev | Date of publication | 202312 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37489552/ | ||
| Article | Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202311 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37632169/ | ||
| Article | Semimechanistic pharmacokinetic-pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy | ||
|---|---|---|---|
| Announcements | CPT Pharmacometrics Syst Pharmacol | Date of publication | 202309 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37559343/ | ||
| Article | Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202307 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37095713/ | ||
| Article | Exploration of smart adherence-monitoring methods in vitamin D-deficient patients: A pilot feasibility clinical study | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202307 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37461832/ | ||
| Article | Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects | ||
|---|---|---|---|
| Announcements | Drug Des Devel Ther | Date of publication | 202307 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37521035/ | ||
| Article | Exploring the Category and Use Cases on Digital Therapeutic Methodologies | ||
|---|---|---|---|
| Announcements | Healthc Inform Res | Date of publication | 202307 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37591674/ | ||
| Article | Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 versus reference tocilizumab: a randomized, double-blind, singledose phase I study | ||
|---|---|---|---|
| Announcements | Expert Opin Investig Drugs | Date of publication | 202305 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37231670/ | ||
| Article | Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects | ||
|---|---|---|---|
| Announcements | Aliment Pharmacol Ther | Date of publication | 202304 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36732884/ | ||
| Article | Continuous versus intermittent infusion of human antithrombin III concentrate in the immediate postoperative period after liver transplantation | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202304 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37038357/ | ||
| Article | Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjects | ||
|---|---|---|---|
| Announcements | Br J Clin Pharmacol | Date of publication | 202304 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36422809/ | ||
| Article | Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazole | ||
|---|---|---|---|
| Announcements | CPT Pharmacometrics Syst Pharmacol | Date of publication | 202303 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36967484/ | ||
| Article | Analysis of the distribution of trial sites in South Korea using social network analysis | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202303 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/37034125/ | ||
| Article | pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202303 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36514192/ | ||
| Article | Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole | ||
|---|---|---|---|
| Announcements | Drug Des Devel Ther | Date of publication | 202302 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36814893/ | ||
| Article | Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration | ||
|---|---|---|---|
| Announcements | Pharmaceuticals (Basel) | Date of publication | 202301 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36678630/ | ||
| Article | Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer | ||
|---|---|---|---|
| Announcements | Lung Cancer | Date of publication | 202301 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36495784/ | ||
| Article | Safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of Vutiglabridin: a first-in-class, first-in-human study | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202211 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36176051/ | ||
| Article | Efficacy and safety of a new ranibizumab biosimilar CKD-701 using a pro re nata treatment regimen in neovascular age-related macular degeneration: A phase 3 randomized clinical trial | ||
|---|---|---|---|
| Announcements | PLoS One | Date of publication | 202211 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36374913/ | ||
| Article | Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy | ||
|---|---|---|---|
| Announcements | Epilepsia | Date of publication | 202211 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36039802/ | ||
| Article | Safety, tolerability, and serum/tear pharmacokinetics of human recombinant epidermal growth factor eyedrops in healthy subjects | ||
|---|---|---|---|
| Announcements | Pharmaceuticals (Basel) | Date of publication | 202210 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36355484/ | ||
| Article | Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugs | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202209 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36247747/ | ||
| Article | A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808 | ||
|---|---|---|---|
| Announcements | CPT Pharmacometrics Syst Pharmacol | Date of publication | 202209 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35748058/ | ||
| Article | Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects | ||
|---|---|---|---|
| Announcements | Br J Clin Pharmacol | Date of publication | 202209 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35395697/ | ||
| Article | Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects | ||
|---|---|---|---|
| Announcements | Front Pharmacol | Date of publication | 202208 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/36071831/ | ||
| Article | Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole | ||
|---|---|---|---|
| Announcements | British journal of clinical pharmacology. | Date of publication | 202207 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35146797/ | ||
| Article | Clinical Evaluation of Digital Therapeutics: Present and Future | ||
|---|---|---|---|
| Announcements | Healthc Inform Res | Date of publication | 202207 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35982593/ | ||
| Article | Comparative Pharmacokinetics Between a Fixed-Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects | ||
|---|---|---|---|
| Announcements | Clinical pharmacology in drug development. | Date of publication | 202205 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34997835/ | ||
| Article | Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension | ||
|---|---|---|---|
| Announcements | Sci Rep | Date of publication | 202205 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35513541/ | ||
| Article | Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects | ||
|---|---|---|---|
| Announcements | Clinical and translational science. | Date of publication | 202205 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35133064/ | ||
| Article | Single-dose of LC51-0255, a selective S1P 1 receptor modulator, showed dose-dependent and reversible reduction of absolute lymphocyte count in humans | ||
|---|---|---|---|
| Announcements | Clinical and translational science. | Date of publication | 202204 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35045208/ | ||
| Article | Cytoplasmic zinc promotes IL-1β production by monocytes and macrophages through mTORC1-induced glycolysis in rheumatoid arthritis | ||
|---|---|---|---|
| Announcements | Science signaling. | Date of publication | 202201 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35015571/ | ||
| Article | Pharmacokinetic and Pharmacodynamic Characteristics of Tripegfilgrastim, a Pegylated G-CSF, in Pediatric Patients with Solid Tumors | ||
|---|---|---|---|
| Announcements | Clin Pharmacol Ther | Date of publication | 202201 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34605552/ | ||
| Article | Trends of clinical trials from 2017 to 2019 in Korea: an integrated analysis based on the Ministry of Food and Drug Safety (MFDS) and the Clinical Research Information Service (CRIS) registries | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202112 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/35024359/ | ||
| Article | Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole | ||
|---|---|---|---|
| Announcements | Drug design, development and therapy. | Date of publication | 202112 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34992346/ | ||
| Article | Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects | ||
|---|---|---|---|
| Announcements | Clin Pharmacol Drug Dev | Date of publication | 202112 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34337876/ | ||
| Article | Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK-30, and From Red Ginseng Extract in Healthy Korean Subjects | ||
|---|---|---|---|
| Announcements | Clin Pharmacol Drug Dev. | Date of publication | 202111 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33884767/ | ||
| Article | The necessary conduct: Exploratory multiregional clinical trials in East Asia | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202111 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34397152/ | ||
| Article | Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non-Japanese | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202110 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34670008/ | ||
| Article | Effects of vancomycin-induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202109 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33982376/ | ||
| Article | Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202109 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34621706/ | ||
| Article | Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids | ||
|---|---|---|---|
| Announcements | Diabetes Res Clin Pract | Date of publication | 202108 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34329692/ | ||
| Article | Pharmacokinetic Equivalence of CT-P17 to High-Concentration (100 mg/mL) Reference Adalimumab: A Randomized Phase I Study in Healthy Subjects | ||
|---|---|---|---|
| Announcements | Clinical and translational science. | Date of publication | 202107 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33503313/ | ||
| Article | Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects | ||
|---|---|---|---|
| Announcements | Drug Design, Development and Therapy | Date of publication | 202106 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34103898/ | ||
| Article | Home-based virtual reality for chronic pain: protocol for an NIH-supported randomised-controlled trial | ||
|---|---|---|---|
| Announcements | BMJ journal | Date of publication | 202106 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34130965/ | ||
| Article | Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication | ||
|---|---|---|---|
| Announcements | Br J Clin Pharmacol | Date of publication | 202106 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34080718/ | ||
| Article | Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate Components | ||
|---|---|---|---|
| Announcements | Clinical pharmacology in drug development | Date of publication | 202106 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34159751/ | ||
| Article | Current bioequivalence study designs in South Korea: a comprehensive analysis of bioequivalence study reports between 2013 and 2019 | ||
|---|---|---|---|
| Announcements | Frontiers in Pharmacology | Date of publication | 202105 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/34045962/ | ||
| Article | Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP�) Biosimilar, to Those of NESP� After a Single Subcutaneous or Intravenous Administration to Healthy Subjects | ||
|---|---|---|---|
| Announcements | Drug Des Devel Ther. | Date of publication | 202104 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33953543/ | ||
| Article | A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators | ||
|---|---|---|---|
| Announcements | Pharmacogenetics and genomics. | Date of publication | 202104 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33165168/ | ||
| Article | Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib | ||
|---|---|---|---|
| Announcements | Pharmaceutics. | Date of publication | 202104 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33925058/ | ||
| Article | A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol. | Date of publication | 202103 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33854997/ | ||
| Article | Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy | ||
|---|---|---|---|
| Announcements | Sci Rep. | Date of publication | 202103 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33737678/ | ||
| Article | Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/ hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202103 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33855001/ | ||
| Article | Pharmacokinetic comparison between tablet of varenicline tartrate and orally disintegrating film of varenicline salicylate in healthy subjects | ||
|---|---|---|---|
| Announcements | Int J Clin Pharmacol Ther | Date of publication | 202103 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33704052/ | ||
| Article | Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol. | Date of publication | 202103 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33855000/ | ||
| Article | Pharmacokinetics and Safety of Extended-release Ranolazine in Korean and White Healthy Subjects | ||
|---|---|---|---|
| Announcements | Clinical therapeutics. | Date of publication | 202103 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33518355/ | ||
| Article | Urinary metabolic markers reflect on hepatic, not intestinal, CYP3A activity in healthy subjects | ||
|---|---|---|---|
| Announcements | Drug Metab Pharmacokinet | Date of publication | 202102 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33348239/ | ||
| Article | Comparison of the Pharmacokinetics of a Fixed-Dose Combination of Rosuvastatin/Metformin Sustained-Release (10/1000 Mg) and Separate Tablets in Healthy Male Subjects | ||
|---|---|---|---|
| Announcements | Clinical pharmacology in drug development | Date of publication | 202102 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32579298/ | ||
| Article | Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study | ||
|---|---|---|---|
| Announcements | Drug Des Devel Ther | Date of publication | 202102 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33628012/ | ||
| Article | The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjects | ||
|---|---|---|---|
| Announcements | Drug Metab Pharmacokinet | Date of publication | 202102 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33348240/ | ||
| Article | Tolerability of lacosamide rapid dose titration: A randomized, multicenter, prospective, open-label study | ||
|---|---|---|---|
| Announcements | Epilepsy Behav | Date of publication | 202102 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33342710/ | ||
| Article | An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans | ||
|---|---|---|---|
| Announcements | Clinical and translational science. | Date of publication | 202101 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33460293/ | ||
| Article | Optimization and validation of a fluorogenic dipeptidyl peptidase 4 enzymatic assay in human plasma | ||
|---|---|---|---|
| Announcements | Analytical biochemistry | Date of publication | 202101 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32926865/ | ||
| Article | Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects | ||
|---|---|---|---|
| Announcements | Aliment Pharmacol Ther | Date of publication | 202012 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33131095/ | ||
| Article | Oral absorption of voriconazole is affected by SLCO2B1 c.*396T>C genetic polymorphism in CYP2C19 poor metabolizers | ||
|---|---|---|---|
| Announcements | Pharmacogenomics J | Date of publication | 202012 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32461666/ | ||
| Article | Effects of perampanel on cognition and quantitative electroencephalography in patients with epilepsy | ||
|---|---|---|---|
| Announcements | Epilepsy Behav | Date of publication | 202012 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33328106/ | ||
| Article | Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities | ||
|---|---|---|---|
| Announcements | Aliment Pharmacol Ther | Date of publication | 202012 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33111337/ | ||
| Article | Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202012 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33425803/ | ||
| Article | Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers | ||
|---|---|---|---|
| Announcements | Transl Clin Pharmacol | Date of publication | 202012 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33425801/ | ||
| Article | Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects | ||
|---|---|---|---|
| Announcements | Drug Des Devel The | Date of publication | 202011 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33262578/ | ||
| Article | Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects | ||
|---|---|---|---|
| Announcements | Drug Des Devel The | Date of publication | 202010 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/33122892/ | ||
| Article | Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-blind, Placebo-controlled Study in Healthy Male Subjects | ||
|---|---|---|---|
| Announcements | Clinical therapeutics. | Date of publication | 202010 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32980184/ | ||
| Article | The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea | ||
|---|---|---|---|
| Announcements | Journal of Korean medical science. | Date of publication | 202009 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32924344/ | ||
| Article | Impact of vancomycin-induced changes in the intestinal microbiota on the pharmacokinetics of simvastatin. | ||
|---|---|---|---|
| Announcements | Clin Transl Sci | Date of publication | 202007 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32058642/ | ||
| Article | Usefulness of saliva for perampanel therapeutic drug monitoring. in Epilepsia has the following publication status | ||
|---|---|---|---|
| Announcements | Epilepsia | Date of publication | 202006 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32378757/ | ||
| Article | Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects | ||
|---|---|---|---|
| Announcements | Clinical pharmacology and therapeutics | Date of publication | 202006 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32271144/ | ||
| Article | An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy Men | ||
|---|---|---|---|
| Announcements | Clinical therapeutics. | Date of publication | 202006 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32362346/ | ||
| Article | Pharmacokinetics of Human Antithrombin III Concentrate in the Immediate Postoperative Period After Liver Transplantation | ||
|---|---|---|---|
| Announcements | British journal of clinical pharmacology | Date of publication | 202005 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/31840271/ | ||
| Article | Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets. | ||
|---|---|---|---|
| Announcements | Drug Des Devel The | Date of publication | 202005 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32546962/ | ||
| Article | Pharmacokinetics and Pharmacodynamics of a Fixed-Dose Combination of gemigliptin/metformin Sustained Release 25/500 Mg Compared to the Loose Combination in Healthy Male Subjects | ||
|---|---|---|---|
| Announcements | Translational and clinical pharmacology | Date of publication | 202003 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32274380/ | ||
| Article | Pharmacokinetics of high-dose carboplatin in children undergoing high-dose chemotherapy and autologous stem cell transplantation with BSA-based dosing. | ||
|---|---|---|---|
| Announcements | Bone marrow transplantation. | Date of publication | 202001 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/31462686/ | ||
| Article | Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects. | ||
|---|---|---|---|
| Announcements | Scientific reports | Date of publication | 201912 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/31857620/ | ||
| Article | Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects. | ||
|---|---|---|---|
| Announcements | TCP | Date of publication | 201912 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32095481/ | ||
| Article | Author Correction : Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction | ||
|---|---|---|---|
| Announcements | Sci Rep | Date of publication | 201911 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/31719650/ | ||
| Article | A fixed-dose combination of gemigliptin and rosuvastatin exhibits similar pharmacokinetics, pharmacodynamics, and safety compared to that of a loose combination in healthy subjects. | ||
|---|---|---|---|
| Announcements | Drug Des Devel Ther | Date of publication | 201911 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/32009778/ | ||
| Article | Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects. | ||
|---|---|---|---|
| Announcements | Clinical therapeutics. | Date of publication | 201911 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/31564513/ | ||
| Article | URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers. | ||
|---|---|---|---|
| Announcements | Rheumatology. | Date of publication | 201911 |
| Co-researcher | |||
| Pubmed URL | https://www.ncbi.nlm.nih.gov/pubmed/31056705/ | ||